These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 23024792)

  • 1. The inhibition of autophagy sensitises colon cancer cells with wild-type p53 but not mutant p53 to topotecan treatment.
    Li DD; Sun T; Wu XQ; Chen SP; Deng R; Jiang S; Feng GK; Pan JX; Zhang XS; Zeng YX; Zhu XF
    PLoS One; 2012; 7(9):e45058. PubMed ID: 23024792
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Autophagy of cancer stem cells is involved with chemoresistance of colon cancer cells.
    Wu S; Wang X; Chen J; Chen Y
    Biochem Biophys Res Commun; 2013 May; 434(4):898-903. PubMed ID: 23624503
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impact of p53 knockout and topotecan treatment on gene expression profiles in human colon carcinoma cells: a pharmacogenomic study.
    Daoud SS; Munson PJ; Reinhold W; Young L; Prabhu VV; Yu Q; LaRose J; Kohn KW; Weinstein JN; Pommier Y
    Cancer Res; 2003 Jun; 63(11):2782-93. PubMed ID: 12782583
    [TBL] [Abstract][Full Text] [Related]  

  • 4. miR-338-3p confers 5-fluorouracil resistance in p53 mutant colon cancer cells by targeting the mammalian target of rapamycin.
    Han J; Li J; Tang K; Zhang H; Guo B; Hou N; Huang C
    Exp Cell Res; 2017 Nov; 360(2):328-336. PubMed ID: 28928082
    [TBL] [Abstract][Full Text] [Related]  

  • 5. ATM-mediated PTEN phosphorylation promotes PTEN nuclear translocation and autophagy in response to DNA-damaging agents in cancer cells.
    Chen JH; Zhang P; Chen WD; Li DD; Wu XQ; Deng R; Jiao L; Li X; Ji J; Feng GK; Zeng YX; Jiang JW; Zhu XF
    Autophagy; 2015; 11(2):239-52. PubMed ID: 25701194
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The nuclear receptor TR3 regulates mTORC1 signaling in lung cancer cells expressing wild-type p53.
    Lee SO; Andey T; Jin UH; Kim K; Singh M; Safe S
    Oncogene; 2012 Jul; 31(27):3265-76. PubMed ID: 22081070
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Anticancer peptidylarginine deiminase (PAD) inhibitors regulate the autophagy flux and the mammalian target of rapamycin complex 1 activity.
    Wang Y; Li P; Wang S; Hu J; Chen XA; Wu J; Fisher M; Oshaben K; Zhao N; Gu Y; Wang D; Chen G; Wang Y
    J Biol Chem; 2012 Jul; 287(31):25941-53. PubMed ID: 22605338
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dehydroandrographolide, an iNOS inhibitor, extracted from Andrographis paniculata (Burm.f.) Nees, induces autophagy in human oral cancer cells.
    Hsieh MJ; Lin CW; Chiou HL; Yang SF; Chen MK
    Oncotarget; 2015 Oct; 6(31):30831-49. PubMed ID: 26356821
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Induction of autophagy counteracts the anticancer effect of cisplatin in human esophageal cancer cells with acquired drug resistance.
    Yu L; Gu C; Zhong D; Shi L; Kong Y; Zhou Z; Liu S
    Cancer Lett; 2014 Dec; 355(1):34-45. PubMed ID: 25236911
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Topotecan-triggered degradation of topoisomerase I is p53-dependent and impacts cell survival.
    Tomicic MT; Christmann M; Kaina B
    Cancer Res; 2005 Oct; 65(19):8920-6. PubMed ID: 16204064
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sustained activation of mTORC1 in macrophages increases AMPKα-dependent autophagy to maintain cellular homeostasis.
    Pan H; Zhong XP; Lee S
    BMC Biochem; 2016 Jul; 17(1):14. PubMed ID: 27387347
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Wild-type p53 protein potentiates cytotoxicity of therapeutic agents in human colon cancer cells.
    Yang B; Eshleman JR; Berger NA; Markowitz SD
    Clin Cancer Res; 1996 Oct; 2(10):1649-57. PubMed ID: 9816112
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fangchinoline induces autophagic cell death via p53/sestrin2/AMPK signalling in human hepatocellular carcinoma cells.
    Wang N; Pan W; Zhu M; Zhang M; Hao X; Liang G; Feng Y
    Br J Pharmacol; 2011 Sep; 164(2b):731-42. PubMed ID: 21418191
    [TBL] [Abstract][Full Text] [Related]  

  • 14. β-asarone inhibited cell growth and promoted autophagy via P53/Bcl-2/Bclin-1 and P53/AMPK/mTOR pathways in Human Glioma U251 cells.
    Wang N; Zhang Q; Luo L; Ning B; Fang Y
    J Cell Physiol; 2018 Mar; 233(3):2434-2443. PubMed ID: 28776671
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Translationally controlled tumour protein TCTP is induced early in human colorectal tumours and contributes to the resistance of HCT116 colon cancer cells to 5-FU and oxaliplatin.
    Bommer UA; Vine KL; Puri P; Engel M; Belfiore L; Fildes K; Batterham M; Lochhead A; Aghmesheh M
    Cell Commun Signal; 2017 Feb; 15(1):9. PubMed ID: 28143584
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Endoplasmic Reticulum Stress Promotes Autophagy and Apoptosis and Reduces Chemotherapy Resistance in Mutant p53 Lung Cancer Cells.
    Gan PP; Zhou YY; Zhong MZ; Peng Y; Li L; Li JH
    Cell Physiol Biochem; 2017; 44(1):133-151. PubMed ID: 29130967
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mimulone-induced autophagy through p53-mediated AMPK/mTOR pathway increases caspase-mediated apoptotic cell death in A549 human lung cancer cells.
    An HK; Kim KS; Lee JW; Park MH; Moon HI; Park SJ; Baik JS; Kim CH; Lee YC
    PLoS One; 2014; 9(12):e114607. PubMed ID: 25490748
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ciclopirox olamine inhibits mTORC1 signaling by activation of AMPK.
    Zhou H; Shang C; Wang M; Shen T; Kong L; Yu C; Ye Z; Luo Y; Liu L; Li Y; Huang S
    Biochem Pharmacol; 2016 Sep; 116():39-50. PubMed ID: 27396756
    [TBL] [Abstract][Full Text] [Related]  

  • 19. TRPC5-induced autophagy promotes drug resistance in breast carcinoma via CaMKKβ/AMPKα/mTOR pathway.
    Zhang P; Liu X; Li H; Chen Z; Yao X; Jin J; Ma X
    Sci Rep; 2017 Jun; 7(1):3158. PubMed ID: 28600513
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibition of autophagy exerts anti-colon cancer effects via apoptosis induced by p53 activation and ER stress.
    Sakitani K; Hirata Y; Hikiba Y; Hayakawa Y; Ihara S; Suzuki H; Suzuki N; Serizawa T; Kinoshita H; Sakamoto K; Nakagawa H; Tateishi K; Maeda S; Ikenoue T; Kawazu S; Koike K
    BMC Cancer; 2015 Oct; 15():795. PubMed ID: 26496833
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.